Stipple Bio
PrivateLast Round
Series A
Apr 6, 2026
Est. Valuation
$2.25B
Total Funding Raised
$121.46M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Stipple Bio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in April 2026.
Stipple Bio is a biotechnology company that develops precision oncology therapies using its Pointillist platform to identify tumor-specific cell surface epitopes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stipple Bio Comparables
Compare Stipple Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TegMine Therapeutics | 77% | |
| Sidewinder Therapeutics | 76% | |
| Day One Biopharmaceuticals | 74% |
For institutional investors. Book with your work email.
Stipple Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 6, 2026 | ||||
| Seed | Dec 20, 2024 | ||||
| Seed | May 31, 2022 |
For institutional investors. Book with your work email.
Stipple Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed, Series A |
| RA Capital Management | Series A |
| GV | Series A |
| GordonMD Global Investments | Series A |
| OMX Ventures | Seed |
| Emerson Collective | Seed, Series A |
| OMX Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Grew 31% QoQ, from 13 to 17 employees.
- Jun 26, 2026
Grew 86% QoQ, from 7 to 13 employees.
For institutional investors. Book with your work email.
Stipple Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stipple Bio's valuation, stock price, and market status.
Is Stipple Bio a public or private company?
Stipple Bio is a private company.
What is the current stock price of Stipple Bio?
Stipple Bio is a private company, so its shares have no public market price. Caplight tracks Stipple Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stipple Bio worth (valuation)?
Stipple Bio's valuation is estimated at $2.3B based on funding round data.
Can I buy Stipple Bio stock?
Stipple Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stipple Bio's last funding round?
Stipple Bio's most recent funding round was Series A on April 6, 2026.
Who are the main investors in Stipple Bio?
Key investors in Stipple Bio include Andreessen Horowitz, RA Capital Management, Nextech Invest.
Will Stipple Bio IPO soon?
No public IPO plans have been announced for Stipple Bio.
How can I track Stipple Bio secondary market activity?
Caplight tracks bids, offers, and trades in Stipple Bio's shares on secondary markets.